Starpharma Год IPO
Что обозначает Год IPO в Starpharma?
Год IPO Starpharma Holdings Limited является 2000
Какое определение для Год IPO?
Первичное публичное размещение акций - это тип публичного предложения, при котором акции компании обычно продаются институциональным инвесторам, которые, в свою очередь, впервые продают эти акции широкой публике на фондовой бирже.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Год IPO компаний в Health Care сектор на ASX по сравнению с Starpharma
Что делает Starpharma?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Компании с год ipo похож на Starpharma
- Arq имеет Год IPO из 1999
- TasFoods имеет Год IPO из 1999
- hopTo имеет Год IPO из 1999
- aap Implantate AG имеет Год IPO из 1999
- Invigor имеет Год IPO из 1999
- Encavis AG имеет Год IPO из 1999
- Starpharma имеет Год IPO из 2000
- SSR Mining Inc имеет Год IPO из 2001
- Bread Inc имеет Год IPO из 2001
- Exact Sciences имеет Год IPO из 2001
- Cross Country Healthcares имеет Год IPO из 2001
- Friedman Industries имеет Год IPO из 2001
- Chevron имеет Год IPO из 2001